TERM ID="NYU_TERM_1" STRING="Additional analyses" FREQUENCY=1 START=2534 END=2553 LEMMA="ADDITIONAL ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Additional work" FREQUENCY=1 START=3130 END=3145 LEMMA="ADDITIONAL WORK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="Caelyx" FREQUENCY=1 START=628 END=634 LEMMA="CAELYX" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Clinical Excellence" FREQUENCY=1 START=357 END=376 LEMMA="CLINICAL EXCELLENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="ERG base-case estimate" FREQUENCY=1 START=3355 END=3377 LEMMA="ERG BASE-CASE ESTIMATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="ET743-OVA-301" FREQUENCY=1 START=830 END=843 LEMMA="ET743-OVA-301" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Kaplan-Meier data" FREQUENCY=1 START=3270 END=3287 LEMMA="KAPLAN-MEIER DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="MTC" FREQUENCY=4 START=1386 END=1389 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_9" STRING="MTC" FREQUENCY=4 START=2120 END=2123 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_10" STRING="MTC" FREQUENCY=4 START=2212 END=2215 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_11" STRING="MTC" FREQUENCY=4 START=2529 END=2532 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_12" STRING="OVA-301 trial" FREQUENCY=1 START=2671 END=2684 LEMMA="OVA-301 TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="PFS results" FREQUENCY=1 START=1756 END=1767 LEMMA="PFS RESULT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="PLDH" FREQUENCY=14 START=621 END=625 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_15" STRING="PLDH" FREQUENCY=14 START=806 END=810 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_16" STRING="PLDH" FREQUENCY=14 START=818 END=822 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_17" STRING="PLDH" FREQUENCY=14 START=1431 END=1435 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_18" STRING="PLDH" FREQUENCY=14 START=1620 END=1624 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_19" STRING="PLDH" FREQUENCY=14 START=2045 END=2049 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_20" STRING="PLDH" FREQUENCY=14 START=2386 END=2390 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_21" STRING="PLDH" FREQUENCY=14 START=2424 END=2428 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_22" STRING="PLDH" FREQUENCY=14 START=2611 END=2615 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_23" STRING="PLDH" FREQUENCY=14 START=2623 END=2627 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_24" STRING="PLDH" FREQUENCY=14 START=2814 END=2818 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_25" STRING="PLDH" FREQUENCY=14 START=2983 END=2987 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_26" STRING="PLDH" FREQUENCY=14 START=3434 END=3438 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_27" STRING="PLDH" FREQUENCY=14 START=3574 END=3578 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_28" STRING="PLDH arm" FREQUENCY=2 START=1869 END=1877 LEMMA="PLDH ARM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_29" STRING="PLDH arm" FREQUENCY=2 START=2024 END=2032 LEMMA="PLDH ARM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_30" STRING="PLDH monotherapy" FREQUENCY=3 START=1639 END=1655 LEMMA="PLDH MONOTHERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_31" STRING="PLDH monotherapy" FREQUENCY=3 START=2826 END=2842 LEMMA="PLDH MONOTHERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_32" STRING="PLDH monotherapy" FREQUENCY=3 START=2995 END=3011 LEMMA="PLDH MONOTHERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_33" STRING="PharmaMar" FREQUENCY=1 START=559 END=568 LEMMA="PHARMAMAR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="QALY" FREQUENCY=4 START=1342 END=1346 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_35" STRING="QALY" FREQUENCY=4 START=2766 END=2770 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_36" STRING="QALY" FREQUENCY=4 START=2935 END=2939 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_37" STRING="QALY" FREQUENCY=4 START=3394 END=3398 LEMMA="QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_38" STRING="QALY of trabectedin" FREQUENCY=1 START=3394 END=3413 LEMMA="TRABECTEDIN QUALITY ADJUSTED LIFE YEAR" LEMMA_FREQUENCY=1 HEAD_TERM="QALY" HEAD_LEMMA="QUALITY ADJUSTED LIFE YEAR"
TERM ID="NYU_TERM_39" STRING="RCT" FREQUENCY=2 START=782 END=785 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_40" STRING="RCT" FREQUENCY=2 START=865 END=868 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_41" STRING="RCT data" FREQUENCY=1 START=1582 END=1590 LEMMA="RCT DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="Schering-Plough" FREQUENCY=1 START=637 END=652 LEMMA="SCHERING-PLOUGH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="Trabectedin" FREQUENCY=1 START=0 END=11 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_44" STRING="Yondelis" FREQUENCY=1 START=548 END=556 LEMMA="YONDELI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="clinical effectiveness" FREQUENCY=1 START=137 END=159 LEMMA="CLINICAL EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="comparing trabectedin" FREQUENCY=1 START=2569 END=2590 LEMMA="COMPARING TRABECTEDIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="comparison evidence" FREQUENCY=1 START=700 END=719 LEMMA="COMPARISON EVIDENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="controlled trial" FREQUENCY=1 START=764 END=780 LEMMA="CONTROLLED TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="cost-effectiveness" FREQUENCY=1 START=164 END=182 LEMMA="COST-EFFECTIVENESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="cost-effectiveness of trabectedin" FREQUENCY=1 START=164 END=197 LEMMA="TRABECTEDIN COST-EFFECTIVENESS" LEMMA_FREQUENCY=1 HEAD_TERM="cost-effectiveness" HEAD_LEMMA="COST-EFFECTIVENESS"
TERM ID="NYU_TERM_51" STRING="de novo cost-effectiveness model" FREQUENCY=1 START=2293 END=2325 LEMMA="DE NOVO COST-EFFECTIVENESS MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="decision problem" FREQUENCY=2 START=478 END=494 LEMMA="DECISION PROBLEM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_53" STRING="decision problem" FREQUENCY=2 START=2246 END=2262 LEMMA="DECISION PROBLEM" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_54" STRING="evidence review group" FREQUENCY=1 START=93 END=114 LEMMA="EVIDENCE REVIEW GROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="exponential distribution" FREQUENCY=1 START=3297 END=3321 LEMMA="EXPONENTIAL DISTRIBUTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="final appraisal determination" FREQUENCY=1 START=3688 END=3717 LEMMA="FINAL APPRAISAL DETERMINATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="formed part" FREQUENCY=1 START=1547 END=1558 LEMMA="FORMED PART" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="key comparators" FREQUENCY=1 START=659 END=674 LEMMA="KEY COMPARATOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="liposomal doxorubicin hydrochloride" FREQUENCY=1 START=584 END=619 LEMMA="LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="manufacturer" FREQUENCY=3 START=289 END=302 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_61" STRING="manufacturer" FREQUENCY=3 START=2268 END=2280 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_62" STRING="manufacturer" FREQUENCY=3 START=3337 END=3349 LEMMA="MANUFACTURER" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_63" STRING="meta-analysis" FREQUENCY=1 START=1391 END=1404 LEMMA="META-ANALYSIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_64" STRING="mixed treatment comparison" FREQUENCY=1 START=1358 END=1384 LEMMA="MIXED TREATMENT COMPARISON" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_65" STRING="monotherapy" FREQUENCY=1 START=2438 END=2449 LEMMA="MONOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_66" STRING="ovarian cancer" FREQUENCY=1 START=42 END=56 LEMMA="OVARIAN CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_67" STRING="paclitaxel" FREQUENCY=2 START=1513 END=1523 LEMMA="PACLITAXEL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_68" STRING="paclitaxel" FREQUENCY=2 START=2398 END=2408 LEMMA="PACLITAXEL" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_69" STRING="patient-level data" FREQUENCY=1 START=3178 END=3196 LEMMA="PATIENT-LEVEL DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_70" STRING="pegylated liposomal doxorubicin hydrochloride" FREQUENCY=1 START=574 END=619 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE" LEMMA_FREQUENCY=15
TERM ID="NYU_TERM_71" STRING="platinum-sensitive ovarian cancer" FREQUENCY=2 START=228 END=261 LEMMA="PLATINUM-SENSITIVE OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_72" STRING="platinum-sensitive ovarian cancer" FREQUENCY=2 START=3620 END=3653 LEMMA="PLATINUM-SENSITIVE OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_73" STRING="platinum-sensitive population" FREQUENCY=4 START=901 END=930 LEMMA="PLATINUM-SENSITIVE POPULATION" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_74" STRING="platinum-sensitive population" FREQUENCY=4 START=1477 END=1506 LEMMA="PLATINUM-SENSITIVE POPULATION" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_75" STRING="platinum-sensitive population" FREQUENCY=4 START=2465 END=2494 LEMMA="PLATINUM-SENSITIVE POPULATION" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_76" STRING="platinum-sensitive population" FREQUENCY=4 START=3487 END=3516 LEMMA="PLATINUM-SENSITIVE POPULATION" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_77" STRING="platinum-sensitive populations" FREQUENCY=3 START=1907 END=1937 LEMMA="PLATINUM-SENSITIVE POPULATION" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_78" STRING="platinum-sensitive populations" FREQUENCY=3 START=2721 END=2751 LEMMA="PLATINUM-SENSITIVE POPULATION" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_79" STRING="platinum-sensitive populations" FREQUENCY=3 START=3084 END=3114 LEMMA="PLATINUM-SENSITIVE POPULATION" LEMMA_FREQUENCY=7
TERM ID="NYU_TERM_80" STRING="platinum-sensitive subgroup" FREQUENCY=1 START=1727 END=1754 LEMMA="PLATINUM-SENSITIVE SUBGROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_81" STRING="progression-free survival" FREQUENCY=1 START=1161 END=1186 LEMMA="PROGRESSION-FREE SURVIVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_82" STRING="quality-adjusted-life-year" FREQUENCY=2 START=1314 END=1340 LEMMA="QUALITY-ADJUSTED-LIFE-YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_83" STRING="quality-adjusted-life-year" FREQUENCY=2 START=1314 END=1340 LEMMA="QUALITY-ADJUSTED-LIFE-YEAR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_84" STRING="randomised controlled trial" FREQUENCY=1 START=753 END=780 LEMMA="RANDOMISED CONTROLLED TRIAL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_85" STRING="reasonable-quality" FREQUENCY=1 START=734 END=752 LEMMA="REASONABLE-QUALITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_86" STRING="response rates" FREQUENCY=1 START=1224 END=1238 LEMMA="RESPONSE RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_87" STRING="single-agent PLDH" FREQUENCY=1 START=1441 END=1458 LEMMA="SINGLE-AGENT PLDH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_88" STRING="statistical fit" FREQUENCY=1 START=3247 END=3262 LEMMA="STATISTICAL FIT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_89" STRING="technology appraisal process" FREQUENCY=1 START=406 END=434 LEMMA="TECHNOLOGY APPRAISAL PROCESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_90" STRING="topotecan" FREQUENCY=1 START=2410 END=2419 LEMMA="TOPOTECAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_91" STRING="trabectedin" FREQUENCY=10 START=186 END=197 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_92" STRING="trabectedin" FREQUENCY=10 START=535 END=546 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_93" STRING="trabectedin" FREQUENCY=10 START=790 END=801 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_94" STRING="trabectedin" FREQUENCY=10 START=1415 END=1426 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_95" STRING="trabectedin" FREQUENCY=10 START=1603 END=1614 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_96" STRING="trabectedin" FREQUENCY=10 START=1853 END=1864 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_97" STRING="trabectedin" FREQUENCY=10 START=2008 END=2019 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_98" STRING="trabectedin" FREQUENCY=10 START=2782 END=2793 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_99" STRING="trabectedin" FREQUENCY=10 START=2951 END=2962 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_100" STRING="trabectedin" FREQUENCY=10 START=3402 END=3413 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=11
TERM ID="NYU_TERM_101" STRING="treatment comparison" FREQUENCY=1 START=1364 END=1384 LEMMA="TREATMENT COMPARISON" LEMMA_FREQUENCY=1
